EUVIMED · CrossrefZeitschrift
Pharmaceuticals Policy and Law
ISSN 1389-2827 · IOS Press
Neueste Artikel
The development risk defence of the EC Product Liability Directive
Some comparative remarks on pharmaceutical product liability
Pharmaceuticals product liability in Brazil
Pharmaceuticals product liability in France
Pharmaceutical products liability in Poland
Pharmaceutical product liability in Spain
Pharmaceutical products liability in the United Kingdom
Product liability for medicinal pharmaceuticals in Germany
Pharmaceuticals products liability in Japan
Some aspects of product pharmaceutical product liability in the United States of America
Pharmaceutical product liability in the United States of America
Pharmaceutical product liability systems: Regulatory models and Challenges
Ethical challenges in the pharmaceutical industry
Corporate responsibility and pharmaceutical fraud
Limits to the legal deliberation of science questions: A case study of borderline medical products in Europe
Study on the effect of “zero mark-up” policy on medicines in Beijing community health facilities
Literature review on entry of medicines in European Small Markets
Current trend in pharmaceutical law in EU
Off-label use of medicines in Argentina. Who wins and who loses?
Pharmacist's role in the studies of the veterinary-medicines-residues depletion
A single European pharmaceutical market: Does maximum harmonization enhance medicinal product innovation?
EU marketing authorization subsequent to dissolution of the transferor and prior to effective transfer
CJD virus, contaminated medicine and prevention technology
The originality and specificity of medicinal product
The pharmaceuticals industry in trouble
Pharmacovigilance and risk management in the EU
The medical devices regulation in the EU ‐ the evolution of the regulatory framework for medical devices
Introduction
Pharmacologic-technical progress and the economics of growth
Induced innovation of the German Employees’ Invention Act
EUVIMED